CN104888128A - Traditional Chinese medicine composition for treatment of cancers - Google Patents

Traditional Chinese medicine composition for treatment of cancers Download PDF

Info

Publication number
CN104888128A
CN104888128A CN201510343985.2A CN201510343985A CN104888128A CN 104888128 A CN104888128 A CN 104888128A CN 201510343985 A CN201510343985 A CN 201510343985A CN 104888128 A CN104888128 A CN 104888128A
Authority
CN
China
Prior art keywords
radix
herba
cancer
rhizoma
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510343985.2A
Other languages
Chinese (zh)
Inventor
周崇立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510343985.2A priority Critical patent/CN104888128A/en
Publication of CN104888128A publication Critical patent/CN104888128A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treatment of cancers. The traditional Chinese medicine composition is prepared by medicinal materials of rhaphiolepis indica, podophyllum, gamboge, fructus camptothecae acuminatae, a wall snake, Artemisia apiacea, peppers, radix ophiopogonis, cynomorium songaricum, sealwort and the like. The traditional Chinese medicine composition has remarkable treatment effect on the various types of cancers of lung cancer, liver cancer, breast cancer, gastric cancer, lymph cancer, intestinal cancer, esophagus cancer, kidney cancer, bladder cancer, pancreatic cancer, melanoma, uterine cancer and the like.

Description

A kind of Chinese medicine composition of Therapeutic cancer
Technical field
The present invention relates to the medicine of Therapeutic cancer, be specifically related to a kind of cancer spirit of going out of the Therapeutic cancer be prepared into by Chinese herbal medicine.
Background technology
Cancer, be the first killer of human health, its mortality rate can up to more than 80%; How all kinds of, each stage cancer of prevention and therapy is the hot-point and frontier sex chromosome mosaicism of world medical circle research.Now mainly chemotherapy is adopted to the treatment doctor trained in Western medicine of cancer, radiotherapy, thermotherapy, the methods such as intervention and operation, these methods generally cause larger injury to health while treatment, if chemotherapy and radiation is while killing cancerous cell, the killing action also stronger to healthy cell, operation can cause larger wound to health, Chinese medicine is due to from cause of disease determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs on the whole, interaction between each ingredient is many, often can produce beyond thought therapeutic effect, and Chinese medicine is to the fanout free region of body, the life quality of patient can be improved completely, world's new standard for cancer of " for cancer and be not harmful to the health " can be met.But clinical Chinese medicine or the Chinese medicine composition rarely having the Therapeutic cancer of determined curative effect now.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of Chinese medicine composition of Therapeutic cancer.Its effect can replace clinical chemotherapy completely.
Technical scheme of the present invention is as follows: a kind of Chinese medicine composition of Therapeutic cancer, is characterized in that, is prepared from by the medicine of following weight: Herba Catharanthi Rosei 8-12g, Rhizoma Dysosmae Versipellis 6-10g, Resina garciniae 2-4g, Fructus Camptothecae Acuminatae 8-12g, Gekko Swinhonis 8-12g, Herba Artemisiae Annuae 8-12g, Pericarpium Zanthoxyli 6-10g, Radix Ophiopogonis 10-20g, Herba Cynomorii 15-25g, Rhizoma Polygonati 15-25g, Flos Lonicerae 20-30g, Scorpio 4-8g, Fructus Forsythiae 10-20g, Scolopendra 4-7g, Herba Bidentis Bipinnatae 20-25g, Poria 10-20g, Herba Pogostemonis 10-20g, Herba Dendrobii 15-25 g, Radix Sophorae Tonkinensis 10-20g, Bulbus Lycoridis Radiatae 8-12g, Radix Polygalae 20-30g, Radix Astragali 18-22g, Radix Tripterygii Wilfordii 12-17g, Rhizoma Gastrodiae 15-25g, Bulbus Fritillariae Cirrhosae 8-12g, Rhizoma Atractylodis Macrocephalae 10-20g, Radix Morindae Officinalis 15-25g, Flos Carthami 10-25g, Rhizoma Curcumae 10-20g, Radix Angelicae Dahuricae 10-20g, Herba Hedyotidis Diffusae 30-40g, Radix Salviae Miltiorrhizae 8-12g, Radix Peucedani 10-20g, Fructus Lycii 15-25g, Fructus Ligustri Lucidi 8-12g, Radix Trichosanthis 10-20g, Radix Panacis Quinquefolii 8-12g, Radix Codonopsis 8-12g, Typhonium flagelliforme (Lodd.) Blume 8-12g, Radix Achyranthis Bidentatae 8-12g, Radix Glycyrrhizae 15-25g, Radix Stephaniae Tetrandrae 8-12g, Herba Artemisiae Scopariae 8-12g, Herba Rabdosiae Lophanthoidis 8-12g, Cordyceps 2-4g, Mylabris 2.
Preparation method is as follows: get Rhizoma Dysosmae Versipellis, Resina garciniae, Herba Catharanthi Rosei, Rhizoma Dysosmae Versipellis, Pericarpium Zanthoxyli, Radix Ophiopogonis, Herba Cynomorii, Flos Lonicerae, Scorpio, Scolopendra, wall Serpentis, Poria, Bulbus Lycoridis Radiatae, Radix Polygalae, the Radix Astragali, Rhizoma Gastrodiae, Bulbus Fritillariae Cirrhosae, Radix Morindae Officinalis, Flos Carthami, Rhizoma Curcumae, the Radix Angelicae Dahuricae, Radix Salviae Miltiorrhizae, Fructus Lycii, Radix Trichosanthis, Radix Panacis Quinquefolii, Radix Codonopsis, Typhonium flagelliforme (Lodd.) Blume, Radix Achyranthis Bidentatae, Radix Stephaniae Tetrandrae, Cordyceps, Mylabris pulverized 80---100 mesh sieve, do not cross sifter and other flavour of a drug add 10 times, 8 times amount soak by water 2 times, earth pot decocting, add a spoon vinegar, each 2 hours, merging filtrate, be concentrated into the concentrated solution that relative density is 1.05-1.10, add above medicated powder, if humidity can not become ball can add water more not, general ball and get final product.
Instructions of taking: honeyed pill or water general be ball, as Semen phaseoli radiati is large.Often take 6 ~ 9 grams, boiled water send down, four times on the one.Take and stop one day in 3 days.
The present invention can adopt modern pharmacy extraction, technology of preparing is further refined medical material, can also add pharmaceutically suitable adjuvant, be prepared into other dosage form, as powder, tablet, capsule, granule etc. dosage form.
Indication: the cancers such as pulmonary carcinoma, hepatocarcinoma, breast carcinoma, gastric cancer, lymphatic cancer, intestinal cancer, esophageal carcinoma, renal carcinoma, bladder cancer, cancer of pancreas, melanoma, uterus carcinoma.
In we, each flavour of a drug are drawn materials exquisite, compatibility science, and the effect reaching and treat various cancer worked in coordination with by each flavour of a drug.Walk internal organs in Scolopendra in side, layman's meridians, and kindization is become silted up removing toxic substances, all heavily fortified points amass stasis part and all thoroughly can reach and send an expedition against, and are the main force assaulted fortified position.Assistant is with Hirudo, and Radix Salviae Miltiorrhizae effect is grander; Radix Sophorae Tonkinensis, Herba Portulacae Grandiflorae, Herba Hedyotidis Diffusae heat-clearing and toxic substances removing and anticancer: Radix Curcumae promoting QI circulation for relieving depression, prolonged illness deficiency of both QI and YIN, with Radix Panacis Quinquefolii, Cordyceps, Herba Cynomorii, Radix Ophiopogonis, Fructus Ligustri Lucidi, Radix Codonopsis, Rhizoma Polygonati with strengthening vital QI to eliminate pathogenic factors, according to clinical experience confirmation for many years: Resina garciniae, Herba Catharanthi Rosei, Rhizoma Dysosmae Versipellis, Fructus Camptothecae Acuminatae, Mylabris etc. combine to have and directly suppress or kill cancerous cell effect.The combination that 7 kinds of said chemotherapeutics of doctor trained in Western medicine extract is had: such as: Herba Catharanthi Rosei can extract vincristine in prescription, vinorelbine, vincaleucoblastine, virosine alkali, also have vindesine and NVB to be extracted into semisynthetic antitumor drug in Herba Catharanthi Rosei; Fructus Camptothecae Acuminatae can extract camptothecine, Guizhou Province base camptothecine; The extract of the chemotherapeutics such as Rhizoma Dysosmae Versipellis can extract etoposide, small cell lung cancer second-line chemotherapy medicine has the effect directly killed or suppress to cancerous cell.The modern medicine Mechanism Study of Chinese herb prevention tumor can direct killing cancerous cell: many Chinese herbal medicine and effective ingredient are by the value-added material base of T suppression cell, as DNA, microtubule and its relevant enzyme, affect tumor cell division and DNA replication dna, direct killing cancerous cell.Colchiceinamidum is extracted from Pseudobulbus Cremastrae Seu Pleiones; The elemene extracted in Rhizoma Curcumae; The effective ingredient indirubin of Indigo Naturalis; Cutis Bufonis can do peace for can, the antineoplastic Chinese traditional medicines such as cinobufacin sheet or cinobufacin pin.Medical research confirms: the poisoning base of Cutis Bufonis (C26H3406): tumor cell rapidly, directly wraps up tumor cell, blocks the source of nutrition of tumor cell, tumor cell cannot be copied and shift; Then enter in cancerous cell core, cut off cancerous cell DNA chain, make apoptosis of tumor cells.Therefore, capture the institute that disease is hard long-pending, recover human body physiological function, thus reach healing object.So, count for clinical experience according to us: cancer is not equal to death, and it is a kind of chronic disease.
Clinical experiment
1,12 Cases of Lung Cancer, wherein male 8 example, women 4 example, 35 ~ 68 years old age, initial stage disease is generally the common symptom of respiratory system disease, as cough, expectorant blood, low grade fever, chest pain, unhappy etc., late period is superior vena cava syndrome: cervical region edema, hoarseness, tachypnea, edema, shoulder arm pain, become thin, weak: the later stage is extensively transferred to bone, liver, brain, kidney adrenal gland, subcutaneous tissue etc.: the course of disease is 3 months ~ 2.5 years; Take this Chinese medicine 90 days, then symptom alleviates to disappearance, then through 270 days consolidate medication treatment, 12 routine patients, 10 example evident in efficacy, 2 examples have certain curative effect, effective percentage 100.0%.
2, gastric cancer 8 example, wherein male 5 example, women 3 example, 34 ~ 59 years old age, the disease initial stage is abdominal discomfort, dull pain, belch, pantothenic acid, loss of appetite, the similar gastroduodenal ulcer of the parts such as anemia or chronic gastritis symptom: and then epigastrium pain, inappetence, become thin, lose weight and anemia: the later stage often has tumor to shift, there is abdominal mass, the enlargement of left clavicle superior gluteal lymph node, melena, ascites and severe malnutrition, the course of disease is 1 ~ 2 year: take this Chinese medicine 90 days, then symptom alleviates to disappearance, then through 270 days consolidate medication treatment, 8 routine patient 7 examples are evident in efficacy, 1 example has certain curative effect, effective percentage 100%.
3, hepatocarcinoma 9 example, wherein male 6 example, women 3 example, at 32 ~ 65 years old age, early hepatocarcinoma can asymptomatic sign, once there is typical clinical manifestation, belongs to mid and late liver cancer.The common sympton of hepatocarcinoma has: hepatalgia, poor appetite, become thin, the heating, abdominal distention, diarrhoea, jaundice etc. of weak and unknown cause.Hepatalgia has tumor growth rate that Glisson's capsule tension force is increased, or tumor is involved caused by Glisson's capsule.It is often the onset symptoms of mid and late liver cancer.Even symptom of digestive tract often shows as, stomach poor appetite moves back, Abdeminal pain Nausea and vomiting or diarrhoea after meal: hepatocarcinoma heating is general at 37.5 DEG C ~ about 38 DEG C, occasionally can reach more than 39 DEG C, in irregular pattern of fever, how not accompany cold station, fever in the afternoon is more common, sometimes also shows the high heat of tension and relaxation type.The course of disease is 1 ~ 2 year.Take this Chinese medicine 90 days, then symptom alleviates to disappearance, then through 270 days consolidate medication treatment, 10 routine patients 1 examples dead (cause of death is not that medicine is invalid), 8 routine curative effects, 1 example has certain curative effect, effective percentage 100.0%.
4, esophageal carcinoma 5 example, wherein male 3 example, women 2 example, age 35-75 year, there is burn feeling when having a meal once in a while or have pain or uncomfortable, the formation of esophageal carcinoma is stimulated by various factors inside and outside mucous membrane of esophagus Normal Goods cell receptor to gradually become cancer, developing into cancer from normal epithelial needs the residing time not clear so far, in general, develop into cancer from esophageal epithelium proliferation and need several years, develop into middle and advanced stage cancer by early cancer again and need about 1 year, the course of disease is 1-2, take this Chinese medicine 90 days, then symptom alleviates to elimination, then through 270 days consolidate medication treatment, 5 routine patients, 4 examples are evident in efficacy, 1 example has certain curative effect, effective percentage is 100%.
5, clinical treatment statistical table is carried out to all kinds of cancer patient of other 50 many cases:
As can be seen from above clinical experiment, the present invention has significant curative effect to various cancer.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated.
embodiment 1
Medicine is taken: Herba Catharanthi Rosei 8g by following prescription, Rhizoma Dysosmae Versipellis 6g, Resina garciniae 2g, Fructus Camptothecae Acuminatae 8g, Gekko Swinhonis 8g, Herba Artemisiae Annuae 8g, Pericarpium Zanthoxyli 6g, Radix Ophiopogonis 10g, Herba Cynomorii 15g, Rhizoma Polygonati 15g, Flos Lonicerae 20g, Scorpio 4g, Fructus Forsythiae 10g, Scolopendra 4g, Herba Bidentis Bipinnatae 20g, Poria 10g, Herba Pogostemonis 10g, Herba Dendrobii 15g, Radix Sophorae Tonkinensis 10g, Bulbus Lycoridis Radiatae 8g, Radix Polygalae 20g, Radix Astragali 18g, Radix Tripterygii Wilfordii 12g, Rhizoma Gastrodiae 15g, Bulbus Fritillariae Cirrhosae 8g, Rhizoma Atractylodis Macrocephalae 10g, Radix Morindae Officinalis 20g, Flos Carthami 10g, Rhizoma Curcumae 10g, Radix Angelicae Dahuricae 10g, Herba Hedyotidis Diffusae 30g, Radix Salviae Miltiorrhizae 8g, Radix Peucedani 10g, Fructus Lycii 15g, Fructus Ligustri Lucidi 8g, Radix Trichosanthis 10g, Radix Panacis Quinquefolii 8g, Radix Codonopsis 8g, Typhonium flagelliforme (Lodd.) Blume 8g, Radix Achyranthis Bidentatae 8g, Radix Glycyrrhizae 15g, Radix Stephaniae Tetrandrae 8g, Herba Artemisiae Scopariae 8g, Herba Rabdosiae Lophanthoidis 8g, Cordyceps 2g, Mylabris 2, preparation method is as follows: get Rhizoma Dysosmae Versipellis, Resina garciniae, Herba Catharanthi Rosei, Rhizoma Dysosmae Versipellis, Pericarpium Zanthoxyli, Radix Ophiopogonis, Herba Cynomorii, Flos Lonicerae, Scorpio, Scolopendra, wall Serpentis, Poria, Bulbus Lycoridis Radiatae, Radix Polygalae, the Radix Astragali, Rhizoma Gastrodiae, Bulbus Fritillariae Cirrhosae, Radix Morindae Officinalis, Flos Carthami, Rhizoma Curcumae, the Radix Angelicae Dahuricae, Radix Salviae Miltiorrhizae, Fructus Lycii, Radix Trichosanthis, Radix Panacis Quinquefolii, Radix Codonopsis, Typhonium flagelliforme (Lodd.) Blume, Radix Achyranthis Bidentatae, Radix Stephaniae Tetrandrae, Cordyceps, Mylabris pulverized 80---100 mesh sieve, do not cross sifter and other flavour of a drug add 10 times, 8 times amount soak by water 2 times, earth pot decocting, add a spoon vinegar, each 2 hours, merging filtrate, be concentrated into the concentrated solution that relative density is 1.05-1.10, add above medicated powder, if humidity can not become ball can add water more not, general ball and get final product.
Embodiment 2
Get Herba Catharanthi Rosei 12g, Rhizoma Dysosmae Versipellis 10g, Resina garciniae 4g, Fructus Camptothecae Acuminatae 12g, Gekko Swinhonis 12g, Herba Artemisiae Annuae 12g, Pericarpium Zanthoxyli 10g, Radix Ophiopogonis 20g, Herba Cynomorii 25g, Rhizoma Polygonati 25g, Flos Lonicerae 30g, Scorpio 8g, Fructus Forsythiae 20g, Scolopendra 7g, Herba Bidentis Bipinnatae 25g, Poria 20g, Herba Pogostemonis 20g, Herba Dendrobii 25 g, Radix Sophorae Tonkinensis 20g, Bulbus Lycoridis Radiatae 12g, Radix Polygalae 30g, Radix Astragali 22g, Radix Tripterygii Wilfordii 17g, Rhizoma Gastrodiae 25g, Bulbus Fritillariae Cirrhosae 12g, Rhizoma Atractylodis Macrocephalae 20g, Radix Morindae Officinalis 25g, Flos Carthami 25g, Rhizoma Curcumae 20g, Radix Angelicae Dahuricae 20g, Herba Hedyotidis Diffusae 40g, Radix Salviae Miltiorrhizae 12g, Radix Peucedani 20g, Fructus Lycii 25g, Fructus Ligustri Lucidi 12g, Radix Trichosanthis 20g, Radix Panacis Quinquefolii 12g, Radix Codonopsis 12g, Typhonium flagelliforme (Lodd.) Blume 12g, Radix Achyranthis Bidentatae 12g, Radix Glycyrrhizae 25g, Radix Stephaniae Tetrandrae 12g, Herba Artemisiae Scopariae 12g, Herba Rabdosiae Lophanthoidis 12g, Cordyceps 4g, Mylabris 2,
Preparation method is with embodiment 1.
Embodiment 3
Get Herba Catharanthi Rosei 10g, Rhizoma Dysosmae Versipellis 8g, Resina garciniae 3g, Fructus Camptothecae Acuminatae 10g, Gekko Swinhonis 10g, Herba Artemisiae Annuae 10g, Pericarpium Zanthoxyli 8g, Radix Ophiopogonis 15g, Herba Cynomorii 20g, Rhizoma Polygonati 20g, Flos Lonicerae 25g, Scorpio 6g, Fructus Forsythiae 15g, Scolopendra 5g, Herba Bidentis Bipinnatae 22g, Poria 15g, Herba Pogostemonis 15g, Herba Dendrobii 20g, Radix Sophorae Tonkinensis 15g, Bulbus Lycoridis Radiatae 10g, Radix Polygalae 25g, Radix Astragali 20g, Radix Tripterygii Wilfordii 15g, Rhizoma Gastrodiae 20g, Bulbus Fritillariae Cirrhosae 10g, Rhizoma Atractylodis Macrocephalae 15g, Radix Morindae Officinalis 20g, Flos Carthami 20g, Rhizoma Curcumae 15g, Radix Angelicae Dahuricae 15g, Herba Hedyotidis Diffusae 35g, Radix Salviae Miltiorrhizae 10g, Radix Peucedani 15g, Fructus Lycii 20g, Fructus Ligustri Lucidi 10g, Radix Trichosanthis 15g, Radix Panacis Quinquefolii 10g, Radix Codonopsis 10g, Typhonium flagelliforme (Lodd.) Blume 10g, Radix Achyranthis Bidentatae 10g, Radix Glycyrrhizae 20g, Radix Stephaniae Tetrandrae 10g, Herba Artemisiae Scopariae 10g, Herba Rabdosiae Lophanthoidis 10g, Cordyceps 3g, Mylabris 2,
Preparation method is with embodiment 1.

Claims (1)

1. a Chinese medicine composition for Therapeutic cancer, is characterized in that, is prepared from by the medicine of following weight: Herba Catharanthi Rosei 8-12g, Rhizoma Dysosmae Versipellis 6-10g, Resina garciniae 2-4g, Fructus Camptothecae Acuminatae 8-12g, Gekko Swinhonis 8-12g, Herba Artemisiae Annuae 8-12g, Pericarpium Zanthoxyli 6-10g, Radix Ophiopogonis 10-20g, Herba Cynomorii 15-25g, Rhizoma Polygonati 15-25g, Flos Lonicerae 20-30g, Scorpio 4-8g, Fructus Forsythiae 10-20g, Scolopendra 4-7g, Herba Bidentis Bipinnatae 20-25g, Poria 10-20g, Herba Pogostemonis 10-20g, Herba Dendrobii 15-25 g, Radix Sophorae Tonkinensis 10-20g, Bulbus Lycoridis Radiatae 8-12g, Radix Polygalae 20-30g, Radix Astragali 18-22g, Radix Tripterygii Wilfordii 12-17g, Rhizoma Gastrodiae 15-25g, Bulbus Fritillariae Cirrhosae 8-12g, Rhizoma Atractylodis Macrocephalae 10-20g, Radix Morindae Officinalis 15-25g, Flos Carthami 10-25g, Rhizoma Curcumae 10-20g, Radix Angelicae Dahuricae 10-20g, Herba Hedyotidis Diffusae 30-40g, Radix Salviae Miltiorrhizae 8-12g, Radix Peucedani 10-20g, Fructus Lycii 15-25g, Fructus Ligustri Lucidi 8-12g, Radix Trichosanthis 10-20g, Radix Panacis Quinquefolii 8-12g, Radix Codonopsis 8-12g, Typhonium flagelliforme (Lodd.) Blume 8-12g, Radix Achyranthis Bidentatae 8-12g, Radix Glycyrrhizae 15-25g, Radix Stephaniae Tetrandrae 8-12g, Herba Artemisiae Scopariae 8-12g, Herba Rabdosiae Lophanthoidis 8-12g, Cordyceps 2-4g, Mylabris 2.
CN201510343985.2A 2015-06-22 2015-06-22 Traditional Chinese medicine composition for treatment of cancers Pending CN104888128A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510343985.2A CN104888128A (en) 2015-06-22 2015-06-22 Traditional Chinese medicine composition for treatment of cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510343985.2A CN104888128A (en) 2015-06-22 2015-06-22 Traditional Chinese medicine composition for treatment of cancers

Publications (1)

Publication Number Publication Date
CN104888128A true CN104888128A (en) 2015-09-09

Family

ID=54021369

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510343985.2A Pending CN104888128A (en) 2015-06-22 2015-06-22 Traditional Chinese medicine composition for treatment of cancers

Country Status (1)

Country Link
CN (1) CN104888128A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108553615A (en) * 2017-12-08 2018-09-21 高良福 Traditional Chinese anti-cancer medicine containing
CN112426491A (en) * 2020-08-15 2021-03-02 仲崇允 Traditional Chinese medicine composition for treating malignant melanoma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110018976A (en) * 2009-08-19 2011-02-25 주식회사 청송제약 An extract with red ginseng and herbs
CN102274361A (en) * 2011-07-29 2011-12-14 李丰曹 Anticancer medicinal composition and preparation method of decoction thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110018976A (en) * 2009-08-19 2011-02-25 주식회사 청송제약 An extract with red ginseng and herbs
CN102274361A (en) * 2011-07-29 2011-12-14 李丰曹 Anticancer medicinal composition and preparation method of decoction thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
姚海扬: "《昆虫药用与食用》", 31 October 2012, 金盾出版社 *
昆山云海中医邹: "群友治疗各种癌经验", 《HTTP://WWW.360DOC.COM/CONTENT/12/0505/13/4920176_208801697.SHTML》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108553615A (en) * 2017-12-08 2018-09-21 高良福 Traditional Chinese anti-cancer medicine containing
CN112426491A (en) * 2020-08-15 2021-03-02 仲崇允 Traditional Chinese medicine composition for treating malignant melanoma

Similar Documents

Publication Publication Date Title
CN103041312B (en) Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof
CN101181529B (en) Chinese medicine composition for curing tumor and preparation method thereof
CN104147534A (en) Traditional Chinese medicine composition for treating various cancers
CN104352608A (en) Traditional Chinese medicine capable of benefiting qi, activating blood circulation, softening hardness, dissipating stagnation, realizing detoxification and relieving pain as well as preparation method thereof
CN103920034B (en) Chinese medicine composition and the method for making of the side reaction of ameliorate tumor chemotherapy of patients
CN102772523B (en) Bitter glossy ganoderma composition for oncotherapy and preparation method of bitter glossy ganoderma composition
CN102688317B (en) Traditional Chinese medicine for treating liver cancer
CN105213974A (en) One treats lymphadenomatous Chinese medicine composition and application thereof
CN101564464B (en) Chinese medicament for adjusting organism immunity of tumor patients
CN104888128A (en) Traditional Chinese medicine composition for treatment of cancers
CN101007159B (en) Traditional Chinese medicine for preventing and controlling tumor
CN104383519A (en) Chinese and western medicine composition curing stomach cancer and preparation method for Chinese and western medicine composition
CN103908616B (en) The medicament of tumor remission patient radiotherapy side effect and preparation method
CN102861292B (en) Medicament for treating esophageal cancer and preparation method thereof
CN103479960A (en) Chronic Hepatitis B disease treatment Chinese herbal
CN1222364A (en) Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof
CN101391074B (en) Medicine composition for treating digestive system carcinoma and preparation method thereof
CN106334140A (en) Traditional Chinese medicine composition and preparation method thereof
CN103919995A (en) Medicine for resisting side effects of postoperative cancer patients and preparation method
CN114869987A (en) A Chinese medicinal composition for preventing and treating hepatocarcinoma
CN105412599A (en) Preparation tablet capable of resisting chemical therapy side effects and strengthening spleen and stomach
CN102552541A (en) Medicinal composition for preventing or treating breast cancer
CN102233117A (en) Traditional Chinese medicine composition for resisting stomach cancer metastasis
CN105412835A (en) Traditional Chinese medicine preparation for treating esophagus benign tumor
CN105031406A (en) Anticancer traditional Chinese medicine preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150909

RJ01 Rejection of invention patent application after publication